Flurazepam Hydrochloride Capsule shortage
Current 6 presentations · 2 manufacturers · first FDA posting Aug 3, 2022 · last update Sep 15, 2026
Manufacturers: Chartwell Molecular Holdings LLC, Rising Pharma Holdings, Inc.
Stated reasons (per FDA): Regulatory delay
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Aug 3, 2022 Updated Sep 15, 2026 | |
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Aug 3, 2022 Updated Sep 15, 2026 | |
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Aug 3, 2022 Updated Sep 15, 2026 | |
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Aug 3, 2022 Updated Sep 15, 2026 | |
| Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | Rising Pharma Holdings, Inc. | Current Unavailable |
Regulatory delay | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Posted Aug 3, 2022 Updated Sep 1, 2026 |
| Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | Rising Pharma Holdings, Inc. | Current Unavailable |
Regulatory delay | Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility. | Posted Aug 3, 2022 Updated Sep 1, 2026 |